Melanoma in situ of lower limb, including hip

melanoma: A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.

Endpoint definition

Name CD2_INSITU_MELANOMA_LOWERLIMB
Long name Melanoma in situ of lower limb, including hip
Level in the ICD-hierarchy 3
First defined in version DF2
Latin name Melanoma in situ coxae

Summary Statistics

Key figures

All Female Male
Number of individuals 62 43 19
Unadjusted prevalence (%) 0.03 0.04 0.02
Mean age at first event (years) 59.75 57.71 64.35
Case fatality at 5-years (%) 3.23 0.00 10.53

Longitudinal metrics

All Female Male
Median nb. of events per indiv. 1.0 1.0 1.0
Recurrence at 6 months (%) 20.97 18.60 26.32

Survival analyses between endpoints

Plot

before Melanoma in situ of lower limb, including hip
after Melanoma in situ of lower limb, including hip

Loading survival analyses plot…

Drugs most likely to be purchased after Melanoma in situ of lower limb, including hip